Predictors of treatment contact among individuals with cannabis dependence

V Agosti, FR Levin - The American journal of drug and alcohol …, 2004 - Taylor & Francis
Epidemiological studies have repeatedly shown that cannabis is the most commonly used
illegal drug in the United States. Furthermore, individuals with cannabis dependence have …

Cannabis for the treatment of attention deficit hyperactivity disorder: a report of 3 cases

H Mansell, D Quinn, LE Kelly, J Alcorn - Medical cannabis and …, 2022 - karger.com
Attention deficit hyperactivity disorder (ADHD) is a chronic neurobehavioral disorder that is
highly prevalent in children and adults. An increasing number of patients with ADHD are self …

Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD

T Torgersen, B Gjervan, K Rasmussen, A Vaaler… - ADHD Attention Deficit …, 2013 - Springer
Central stimulant (CS) therapy is a cornerstone in treatment of adult attention-
deficit/hyperactivity disorder (ADHD). Substance use disorder (SUD) is a common comorbid …

Psychiatric comorbidity and addiction severity differences in patients with ADHD seeking treatment for cannabis or cocaine use disorders

N Martínez-Luna, C Daigre… - Journal of Attention …, 2021 - journals.sagepub.com
Objective: The objective of this study was to compare psychiatric comorbidity and
consumption-related variables in ADHD patients seeking treatment for cocaine, cannabis, or …

Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study

EA McClure, NL Baker, SC Sonne, UE Ghitza… - Drug and alcohol …, 2018 - Elsevier
Background It is common for cannabis users to also use tobacco. While data suggest that
tobacco users have more difficulty achieving cannabis cessation, secondary analyses of …

Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic

T Weizman, M Gelkopf, Y Melamed… - Australian & New …, 2004 - journals.sagepub.com
Objective: We addressed the following questions. What are the current and lifetime
prevalence of cannabis abuse in an Israeli methadone maintenance treatment (MMT) clinic …

High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis

ME Socías, E Wood, S Lake, S Nolan, N Fairbairn… - …, 2018 - Wiley Online Library
Abstract Background and Aims Cannabis use is common among people on opioid agonist
treatment (OAT), causing concern for some care providers. However, there is limited and …

Natural outcome of cannabis use disorder: a 3‐year longitudinal follow‐up

D Feingold, J Fox, J Rehm, S Lev‐Ran - Addiction, 2015 - Wiley Online Library
Aims To assess the prevalence and correlates of remission from cannabis use disorders
(CUDs), focusing on the proportion of individuals with CUDs that remit without abstaining …

Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.

BJ Sherman, MJ Sofis, JT Borodovsky… - … of addictive behaviors, 2022 - psycnet.apa.org
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …

Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain

BE Perron, KR Holt, E Yeagley, M Ilgen - Drug and Alcohol Dependence, 2019 - Elsevier
Purpose: To describe patterns of cannabis withdrawal among a large sample of those who
use medical cannabis and test the association between withdrawal symptomology and …